SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Labrador who wrote (503)1/1/1998 12:03:00 PM
From: Mama Bear  Read Replies (1) of 1837
 
bob, I'm mostly a short term trader, and recently the play with these FDA approvals is to go long (I bought DRMD at 3 1/2) when the approval is released, sell after some resistance (sold it way too soon), and look for a short entry. In just the last week I did this successfully with CEPH and RBOT. The buying strength in this stock over the last few days gives me pause on the short side. Especially when you couple the fact that the price had been as high as 12 1/4 this year and that this happened the last 2 days of the year. There should have been tax selling. At this point in time I'm doubtful that I will short, unless the run up continues. You might be better served to consider some Jan 5 puts (DUQMA) which are only asking 3/16. While it's not that long until expiry, if it sustains this price or even runs up you'll only lose the 3/16. If it turns around, there will be some premium built into the price. Oh, the fact that the puts are only asking 3/16 says to me that the options specialist are impressed with the upward movement.

Hope this helps,

Barb
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext